Dorman Products (DORM) Financials

$116.32 -3.20 (-2.68%)

Closing price 05/13/2026 04:00 PM Eastern

Extended Trading

$116.32 0.00 (0.00%)

As of 04:26 AM Eastern

Annual Income Statements for Dorman Products

This table shows Dorman Products' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/26/2015	12/31/2016	12/30/2017	12/29/2018	12/28/2019	12/26/2020	12/25/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Net Income / (Loss) Attributable to Common Shareholders	92	106	107	134	84	107	130	120	130	186	206
Consolidated Net Income / (Loss)	92	106	107	134	84	107	132	122	129	190	204
Net Income / (Loss) Continuing Operations	92	106	107	134	84	107	132	122	129	190	204
Total Pre-Tax Income	146	168	177	171	106	136	170	156	169	256	275
Total Operating Income	146	169	176	171	106	133	172	171	215	293	300
Total Gross Profit	308	338	359	373	340	383	463	564	685	806	898
Total Revenue	803	860	903	974	991	1,093	1,345	1,734	1,930	2,009	2,130
Operating Revenue	803	860	903	974	991	1,093	1,345	1,734	1,930	2,009	2,130
Total Cost of Revenue	495	522	545	600	652	710	882	1,169	1,244	1,203	1,233
Operating Cost of Revenue	495	522	545	600	652	710	882	1,169	1,244	1,203	1,233
Total Operating Expenses	162	169	182	202	234	250	291	393	471	513	598
Selling, General & Admin Expense	162	169	182	202	234	250	291	393	471	513	541
Impairment Charge	-	-	-	-	-	-	-	-	0.00	0.00	57
Total Other Income / (Expense), net	-0.22	-0.24	0.35	-0.01	-0.02	2.36	-1.79	-15	-46	-37	-24
Interest Expense	-	-	-	-	0.23	0.60	2.16	16	48	40	29
Other Income / (Expense), net	-0.22	-0.24	0.35	-0.01	0.21	2.96	0.38	0.74	1.80	3.07	4.47
Income Tax Expense	54	62	70	38	22	29	38	35	39	66	71
Other Adjustments to Net Income / (Loss) Attributable to Common Shareholders)	-	-	-	-	0.00	-	1.44	1.86	-0.71	4.19	-2.25
Basic Earnings per Share	$2.60	$3.07	$3.14	$4.04	$2.57	$3.31	$4.13	$3.87	$4.11	$6.17	$6.69
Weighted Average Basic Shares Outstanding	35.47M	34.52M	33.96M	33.10M	32.61M	32.28M	31.81M	31.43M	31.46M	30.80M	30.54M
Diluted Earnings per Share	$2.60	$3.07	$3.13	$4.02	$2.56	$3.30	$4.12	$3.85	$4.10	$6.14	$6.64
Weighted Average Diluted Shares Outstanding	35.54M	34.60M	34.05M	33.21M	32.69M	32.37M	31.96M	31.54M	31.53M	30.96M	30.76M
Weighted Average Basic & Diluted Shares Outstanding	35.50M	34.50M	33.90M	33.10M	32.55M	32.18M	31.55M	31.45M	31.09M	30.58M	30.18M

This table shows Dorman Products' income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Period end date	9/30/2023	12/31/2023	3/30/2024	6/29/2024	9/28/2024	12/31/2024	3/29/2025	6/28/2025	9/27/2025	12/31/2025	3/28/2026
Net Income / (Loss) Attributable to Common Shareholders	39	52	32	47	56	51	58	61	75	12	43
Consolidated Net Income / (Loss)	41	50	33	47	55	55	58	59	76	12	44
Net Income / (Loss) Continuing Operations	41	50	33	47	55	55	58	59	76	12	44
Total Pre-Tax Income	53	66	44	62	71	79	74	77	100	25	56
Total Operating Income	64	77	54	72	79	87	80	82	106	31	59
Total Gross Profit	183	194	181	199	204	222	208	220	241	229	190
Total Revenue	488	494	469	503	504	534	508	541	544	538	529
Operating Revenue	488	494	469	503	504	534	508	541	544	538	529
Total Cost of Revenue	305	300	287	304	300	312	300	321	302	309	339
Operating Cost of Revenue	305	300	287	304	300	312	300	321	302	309	339
Total Operating Expenses	119	117	127	127	125	135	128	137	136	198	131
Selling, General & Admin Expense	119	117	127	127	125	135	128	137	136	141	131
Total Other Income / (Expense), net	-12	-11	-11	-10	-8.15	-7.80	-6.00	-5.64	-5.82	-6.65	-2.56
Interest Expense	12	11	11	10	9.76	9.16	7.36	7.18	7.21	6.83	5.81
Other Income / (Expense), net	0.61	0.45	-0.04	0.14	1.62	1.36	1.36	1.54	1.39	0.18	3.25
Income Tax Expense	12	16	11	15	16	24	17	18	24	13	13
Other Adjustments to Net Income / (Loss) Attributable to Common Shareholders)	1.21	-1.24	1.10	0.52	-0.65	3.22	-0.22	-2.34	1.00	-0.69	0.40
Basic Earnings per Share	$1.29	$1.60	$1.05	$1.53	$1.81	$1.78	$1.88	$1.92	$2.50	$0.39	$1.44
Weighted Average Basic Shares Outstanding	31.48M	31.46M	31.14M	30.96M	30.57M	30.80M	30.58M	30.52M	30.55M	30.54M	30.23M
Diluted Earnings per Share	$1.28	$1.60	$1.05	$1.53	$1.80	$1.76	$1.87	$1.91	$2.48	$0.38	$1.43
Weighted Average Diluted Shares Outstanding	31.56M	31.53M	31.25M	31.07M	30.74M	30.96M	30.81M	30.68M	30.78M	30.76M	30.42M
Weighted Average Basic & Diluted Shares Outstanding	31.49M	31.09M	31.01M	30.57M	30.52M	30.58M	30.51M	30.53M	30.56M	30.18M	29.88M

This table details how cash moves in and out of Dorman Products' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/26/2015	12/31/2016	12/30/2017	12/29/2018	12/28/2019	12/26/2020	12/25/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Net Change in Cash & Equivalents	31	70	-77	-28	25	87	-97	-13	-9.22	20	-7.70
Net Cash From Operating Activities	92	122	94	78	95	152	100	42	209	231	114
Net Cash From Continuing Operating Activities	92	122	94	78	95	152	100	42	209	231	114
Net Income / (Loss) Continuing Operations	92	106	107	134	84	107	132	122	129	190	204
Consolidated Net Income / (Loss)	92	106	107	134	84	107	132	122	129	190	204
Depreciation Expense	16	19	22	28	26	32	35	45	55	57	56
Non-Cash Adjustments To Reconcile Net Income	4.14	3.60	3.46	2.89	3.12	55	5.99	9.34	16	15	77
Changes in Operating Assets and Liabilities, net	-21	-7.02	-38	-87	-17	-42	-72	-134	8.69	-31	-223
Net Cash From Investing Activities	-24	-26	-94	-59	-30	-30	-365	-527	-44	-39	-38
Net Cash From Continuing Investing Activities	-24	-26	-94	-59	-30	-30	-365	-527	-44	-39	-38
Purchase of Property, Plant & Equipment	-22	-20	-24	-26	-30	-15	-20	-38	-44	-39	-38
Acquisitions	0.00	0.00	-60	-28	0.00	-15	-345	-489	0.07	0.10	0.00
Net Cash From Financing Activities	-37	-25	-77	-47	-41	-34	168	472	-174	-171	-84
Net Cash From Continuing Financing Activities	-37	-25	-77	-47	-41	-34	168	472	-174	-171	-84
Repayment of Debt	-	-	-	0.00	0.00	-99	-17	-17	-159	-94	-42
Repurchase of Common Equity	-	-25	-76	-45	-41	-	-63	-20	-16	-81	-41
Other Financing Activities, net	-37	-0.15	-1.14	-1.59	0.49	-34	-4.26	-0.53	0.70	4.46	-1.01
Other Net Changes in Cash	-	-	-	-	0.00	0.00	-0.04	-0.09	0.03	-0.42	0.32
Cash Interest Paid	0.28	0.27	0.29	0.25	0.34	0.75	1.78	12	50	39	27
Cash Income Taxes Paid	57	62	75	30	29	28	46	63	35	57	69

This table details how cash moves in and out of Dorman Products' business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Period end date	9/30/2023	12/31/2023	3/30/2024	6/29/2024	9/28/2024	12/31/2024	3/29/2025	6/28/2025	9/27/2025	12/31/2025	3/28/2026
Net Change in Cash & Equivalents	-3.71	4.86	-2.38	13	-2.34	12	3.48	-3.77	-1.34	-6.07	-6.38
Net Cash From Operating Activities	56	60	52	63	44	71	51	8.55	12	42	44
Net Cash From Continuing Operating Activities	56	60	52	63	44	71	51	8.55	12	42	44
Net Income / (Loss) Continuing Operations	41	50	33	47	55	55	58	59	76	12	44
Consolidated Net Income / (Loss)	41	50	33	47	55	55	58	59	76	12	44
Depreciation Expense	14	14	14	14	15	14	14	14	14	14	14
Non-Cash Adjustments To Reconcile Net Income	3.34	4.95	2.94	3.82	3.86	4.48	3.93	4.86	4.01	64	4.02
Changes in Operating Assets and Liabilities, net	-1.45	-9.53	2.36	-2.24	-30	-1.25	-24	-69	-82	-48	-18
Net Cash From Investing Activities	-9.67	-11	-11	-12	-8.56	-8.08	-11	-8.45	-10	-8.15	-8.45
Net Cash From Continuing Investing Activities	-9.67	-11	-11	-12	-8.56	-8.08	-11	-8.45	-10	-8.15	-8.45
Purchase of Property, Plant & Equipment	-9.67	-11	-11	-12	-8.56	-8.18	-11	-8.45	-10	-8.15	-8.45
Net Cash From Financing Activities	-50	-44	-44	-38	-38	-51	-37	-4.04	-3.12	-40	-42
Net Cash From Continuing Financing Activities	-50	-44	-44	-38	-38	-51	-37	-4.04	-3.12	-40	-42
Repayment of Debt	-50	-30	-15	-15	-11	-54	-20	-	-6.25	-16	0.00
Repurchase of Common Equity	-0.18	-15	-28	-24	-28	-0.89	-11	-4.29	-0.21	-25	-51
Issuance of Debt	-	-	-	-	-	-	0.00	-	-	-	15
Other Financing Activities, net	-0.01	0.92	-1.23	0.89	0.61	4.19	-5.33	0.25	3.34	0.72	-6.18
Other Net Changes in Cash	-0.06	0.05	-0.04	-0.02	0.03	-0.39	0.03	0.17	-0.04	0.16	-0.00
Cash Interest Paid	12	11	10	9.94	6.53	12	4.58	6.93	6.87	8.98	3.58
Cash Income Taxes Paid	12	8.22	0.84	26	13	17	0.52	42	11	15	1.60

This table presents Dorman Products' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/26/2015	12/31/2016	12/30/2017	12/29/2018	12/28/2019	12/26/2020	12/25/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Total Assets	622	712	766	978	1,041	1,221	1,673	2,342	2,292	2,425	2,493
Total Current Assets	479	552	533	720	755	923	1,077	1,269	1,234	1,370	1,522
Cash & Equivalents	79	149	72	43	68	156	59	46	37	57	49
Accounts Receivable	204	231	242	401	392	461	473	427	527	574	479
Inventories, net	194	169	212	271	281	299	532	756	637	708	959
Prepaid Expenses	2.33	3.12	7.13	5.65	14	7.76	13	40	33	31	34
Plant, Property, & Equipment, net	87	88	93	99	102	91	115	148	160	164	169
Total Noncurrent Assets	56	72	140	159	185	207	482	924	899	890	803
Goodwill	30	28	66	73	74	91	197	443	444	443	387
Intangible Assets	-	1.64	22	25	21	25	179	322	302	278	257
Other Noncurrent Operating Assets	19	30	44	55	85	78	106	159	153	163	158
Total Liabilities & Shareholders' Equity	622	712	766	978	1,041	1,221	1,673	2,342	2,292	2,425	2,493
Total Liabilities	104	110	131	250	267	367	740	1,299	1,124	1,131	1,016
Total Current Liabilities	99	104	111	232	221	323	665	678	547	564	493
Short-Term Debt	-	-	-	-	-	0.00	239	252	108	42	38
Accounts Payable	64	73	80	109	90	118	177	180	177	232	185
Accrued Expenses	24	19	18	109	120	185	222	227	238	246	239
Current Employee Benefit Liabilities	11	12	12	15	9.78	20	27	19	24	44	31
Total Noncurrent Liabilities	5.26	6.30	20	18	47	44	75	621	577	567	523
Long-Term Debt	-	-	-	-	-	-	-	482	467	440	402
Capital Lease Obligations	-	-	-	0.00	30	37	-	98	91	105	97
Noncurrent Deferred & Payable Income Tax Liabilities	-	0.00	6.60	4.79	3.96	3.82	18	12	8.93	3.70	3.98
Other Noncurrent Operating Liabilities	5.26	6.30	14	14	13	3.56	57	28	9.63	19	20
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	518	602	635	728	774	854	933	1,043	1,168	1,293	1,477
Total Preferred & Common Equity	518	602	635	728	774	854	933	1,043	1,168	1,293	1,477
Total Common Equity	518	602	635	728	774	854	933	1,043	1,168	1,293	1,477
Common Stock	43	45	45	48	53	64	78	89	101	119	137
Retained Earnings	475	557	590	679	721	789	856	957	1,069	1,181	1,344
Accumulated Other Comprehensive Income / (Loss)	-	-	-	-	-	0.00	-1.44	-3.30	-2.59	-6.78	-4.52

This table presents Dorman Products' assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q1 2023	Q2 2023	Q3 2023	Q1 2024	Q2 2024	Q3 2024	Q1 2025	Q2 2025	Q3 2025	Q1 2026
Period end date	9/24/2022	4/1/2023	7/1/2023	9/30/2023	3/30/2024	6/29/2024	9/28/2024	3/29/2025	6/28/2025	9/27/2025	3/28/2026
Total Assets	1,801	2,261	2,257	2,260	2,220	2,286	2,364	2,428	2,471	2,553	2,435
Total Current Assets	1,177	1,190	1,189	1,195	1,163	1,233	1,316	1,376	1,427	1,517	1,475
Cash & Equivalents	35	33	36	32	34	47	45	61	57	56	43
Accounts Receivable	433	429	453	484	486	526	571	555	532	521	503
Inventories, net	678	687	643	626	620	620	665	735	798	900	902
Prepaid Expenses	30	40	58	53	22	39	35	26	40	41	27
Plant, Property, & Equipment, net	122	152	157	158	162	166	166	167	167	168	167
Total Noncurrent Assets	502	919	912	907	895	887	882	885	878	867	793
Goodwill	196	443	444	443	443	443	443	443	444	444	387
Intangible Assets	169	317	313	307	296	290	284	273	268	262	252
Other Noncurrent Operating Assets	137	159	155	157	156	154	155	163	160	161	154
Total Liabilities & Shareholders' Equity	1,801	2,261	2,257	2,260	2,220	2,286	2,364	2,428	2,471	2,553	2,435
Total Liabilities	780	1,212	1,171	1,132	1,046	1,084	1,129	1,090	1,072	1,070	968
Total Current Liabilities	674	607	570	533	466	514	561	526	520	517	448
Short-Term Debt	229	228	179	132	94	85	81	22	31	34	53
Accounts Payable	199	146	152	158	131	165	206	221	221	215	134
Accrued Expenses	230	219	224	227	222	242	248	262	243	242	244
Current Employee Benefit Liabilities	16	15	15	16	18	22	27	21	24	26	18
Total Noncurrent Liabilities	106	605	600	599	580	570	568	564	552	553	520
Long-Term Debt	-	479	476	473	467	461	455	440	430	421	403
Capital Lease Obligations	84	97	93	95	93	90	94	101	98	99	93
Noncurrent Deferred & Payable Income Tax Liabilities	17	12	15	15	9.35	9.32	9.64	3.71	3.80	12	3.87
Other Noncurrent Operating Liabilities	5.16	17	16	15	10	10	9.20	19	20	20	21
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	1,021	1,049	1,086	1,128	1,174	1,201	1,235	1,337	1,400	1,483	1,467
Total Preferred & Common Equity	1,021	1,049	1,086	1,128	1,174	1,201	1,235	1,337	1,400	1,483	1,467
Total Common Equity	1,021	1,049	1,086	1,128	1,174	1,201	1,235	1,337	1,400	1,483	1,467
Common Stock	86	91	95	98	103	107	111	117	122	130	135
Retained Earnings	939	962	994	1,034	1,076	1,099	1,127	1,226	1,282	1,358	1,337
Accumulated Other Comprehensive Income / (Loss)	-3.86	-3.18	-2.62	-3.83	-3.69	-4.21	-3.56	-6.55	-4.21	-5.21	-4.92

This table displays calculated financial ratios and metrics derived from Dorman Products' official financial filings.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/26/2015	12/31/2016	12/30/2017	12/29/2018	12/28/2019	12/26/2020	12/25/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
DEI Shares Outstanding	-	-	-	-	-	-	-	-	-	-	30,562,644.00
DEI Adjusted Shares Outstanding	-	-	-	-	-	-	-	-	-	-	30,562,644.00
DEI Earnings Per Adjusted Shares Outstanding	-	-	-	-	-	-	-	-	-	-	6.75
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Net Operating Profit after Tax (NOPAT)	92	106	106	134	84	105	133	133	165	217	222
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	-	-	-	-	7.10%	8.98%	11.55%	11.03%
Earnings before Interest and Taxes (EBIT)	146	168	177	171	106	136	172	172	217	296	304
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	162	187	199	200	132	169	207	216	271	353	360
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	67	93	-4.21	13	33	105	-245	-583	196	192	81
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	439	453	563	684	735	735	1,113	1,829	1,798	1,823	1,964
Increase / (Decrease) in Invested Capital	25	13	111	121	51	0.11	378	716	-31	25	141
Book Value per Share	$14.59	$17.38	$18.82	$22.02	$23.60	$26.44	$29.49	$33.19	$37.10	$42.38	$48.33
Tangible Book Value per Share	$13.75	$16.52	$16.21	$19.06	$20.68	$22.84	$17.60	$8.82	$13.43	$18.76	$27.24
Total Capital	518	602	635	728	803	891	1,172	1,875	1,835	1,880	2,014
Total Debt	0.00	0.00	0.00	0.00	30	37	239	833	667	587	536
Total Long-Term Debt	0.00	0.00	0.00	0.00	30	37	0.00	581	559	545	499
Net Debt	-79	-149	-72	-43	-39	-118	181	787	630	530	487
Capital Expenditures (CapEx)	22	20	24	26	30	15	20	38	44	39	38
Debt-free, Cash-free Net Working Capital (DFCFNWC)	301	299	350	445	466	445	592	797	758	791	1,017
Debt-free Net Working Capital (DFNWC)	380	448	422	488	534	600	651	843	795	848	1,066
Net Working Capital (NWC)	380	448	422	488	534	600	412	591	687	806	1,029
Net Nonoperating Expense (NNE)	0.14	0.15	-0.21	0.01	0.02	-1.86	1.38	12	35	27	18
Net Nonoperating Obligations (NNO)	-79	-149	-72	-43	-39	-118	181	787	630	530	487
Total Depreciation and Amortization (D&A)	16	19	22	28	26	32	35	45	55	57	56
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$2.60	$3.07	$3.14	$4.04	$2.57	$3.31	$4.13	$3.87	$4.11	$6.17	$6.69
Adjusted Weighted Average Basic Shares Outstanding	35.47M	34.52M	33.96M	33.10M	32.61M	32.28M	31.81M	31.43M	31.46M	30.80M	30.54M
Adjusted Diluted Earnings per Share	$2.60	$3.07	$3.13	$4.02	$2.56	$3.30	$4.12	$3.85	$4.10	$6.14	$6.64
Adjusted Weighted Average Diluted Shares Outstanding	35.54M	34.60M	34.05M	33.21M	32.69M	32.37M	31.96M	31.54M	31.53M	30.96M	30.76M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	34.78M	34.55M	33.57M	32.99M	32.55M	32.18M	31.55M	31.45M	31.09M	30.58M	30.18M
Normalized Net Operating Profit after Tax (NOPAT)	92	106	106	134	84	105	133	133	165	217	264
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-

This table displays calculated financial ratios and metrics derived from Dorman Products' official financial filings.

Metric	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Period end date	9/30/2023	12/31/2023	3/30/2024	6/29/2024	9/28/2024	12/31/2024	3/29/2025	6/28/2025	9/27/2025	12/31/2025	3/28/2026
DEI Shares Outstanding	-	-	-	-	-	-	-	-	-	30,562,644.00	30,183,260.00
DEI Adjusted Shares Outstanding	-	-	-	-	-	-	-	-	-	30,562,644.00	30,183,260.00
DEI Earnings Per Adjusted Shares Outstanding	-	-	-	-	-	-	-	-	-	0.40	1.43
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	18.07%	-1.39%	0.42%	4.66%	3.19%	7.99%	8.32%	7.56%	7.93%	-	4.15%
EBITDA Growth	46.80%	95.28%	113.20%	25.96%	21.71%	11.09%	39.60%	12.66%	26.62%	-	-20.21%
EBIT Growth	54.20%	132.75%	194.50%	30.57%	24.80%	13.41%	49.70%	15.76%	32.45%	-	-23.83%
NOPAT Growth	52.40%	129.66%	158.38%	30.98%	24.49%	2.34%	52.33%	14.45%	31.32%	-	-26.75%
Net Income Growth	32.42%	181.92%	477.65%	44.68%	36.35%	8.41%	75.17%	23.83%	38.31%	-	-24.27%
EPS Growth	31.96%	180.70%	483.33%	47.12%	40.63%	10.00%	78.10%	24.84%	37.78%	-	-23.53%
Operating Cash Flow Growth	799.13%	383.21%	98.32%	-4.99%	-21.22%	19.74%	-1.43%	-86.51%	-72.44%	-	-14.59%
Free Cash Flow Firm Growth	-282.20%	112.95%	111.46%	112.75%	108.73%	-60.74%	-75.03%	-177.49%	-308.52%	-	-621.98%
Invested Capital Growth	38.33%	-1.69%	-1.41%	-0.49%	1.25%	1.38%	2.54%	6.28%	8.93%	-	7.18%
Revenue Q/Q Growth	1.59%	1.25%	-5.18%	7.31%	0.16%	5.95%	-4.89%	6.55%	0.51%	-	-1.70%
EBITDA Q/Q Growth	13.92%	16.53%	-25.52%	27.39%	10.07%	6.37%	-6.40%	2.80%	23.71%	-	67.61%
EBIT Q/Q Growth	16.58%	19.86%	-29.98%	33.44%	11.43%	8.93%	-7.57%	3.18%	27.50%	-	97.39%
NOPAT Q/Q Growth	17.67%	18.32%	-30.28%	34.92%	11.85%	-2.73%	3.78%	1.38%	28.34%	-	210.12%
Net Income Q/Q Growth	23.66%	24.09%	-34.71%	44.42%	16.54%	-1.34%	5.49%	2.09%	30.17%	-	276.74%
EPS Q/Q Growth	23.08%	25.00%	-34.38%	45.71%	17.65%	-2.22%	6.25%	2.14%	29.84%	-	276.32%
Operating Cash Flow Q/Q Growth	-15.68%	6.09%	-12.86%	21.87%	-30.08%	61.26%	-28.26%	-83.32%	42.78%	-	5.08%
Free Cash Flow Firm Q/Q Growth	10.42%	119.93%	-25.67%	-3.95%	-38.66%	-10.35%	-52.72%	-398.06%	-65.07%	-	31.45%
Invested Capital Q/Q Growth	-0.09%	0.08%	-0.23%	-0.25%	1.65%	0.21%	0.91%	3.40%	4.19%	-	0.40%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	37.53%	39.29%	38.71%	39.65%	40.46%	41.54%	40.91%	40.58%	44.40%	-	35.96%
EBITDA Margin	16.11%	18.54%	14.56%	17.29%	19.00%	19.07%	18.77%	18.11%	22.28%	-	14.38%
Operating Margin	13.15%	15.63%	11.61%	14.41%	15.74%	16.25%	15.77%	15.25%	19.45%	-	11.12%
EBIT Margin	13.28%	15.72%	11.61%	14.43%	16.06%	16.51%	16.04%	15.53%	19.70%	-	11.73%
Profit (Net Income) Margin	8.30%	10.17%	7.00%	9.43%	10.97%	10.21%	11.33%	10.85%	14.05%	-	8.24%
Tax Burden Percent	77.04%	75.78%	74.96%	75.99%	77.69%	69.05%	77.63%	76.40%	76.48%	-	77.46%
Interest Burden Percent	81.15%	85.42%	80.50%	85.95%	87.93%	89.61%	90.96%	91.45%	93.27%	-	90.64%
Effective Tax Rate	22.96%	24.22%	25.04%	24.01%	22.31%	30.95%	22.37%	23.60%	23.52%	-	22.54%
Return on Invested Capital (ROIC)	12.68%	12.60%	9.31%	11.92%	13.32%	12.45%	13.80%	13.17%	16.64%	-	9.72%
ROIC Less NNEP Spread (ROIC-NNEP)	10.79%	11.43%	8.16%	10.75%	12.31%	11.52%	12.97%	12.38%	15.82%	-	9.33%
Return on Net Nonoperating Assets (RNNOA)	4.75%	7.33%	5.10%	6.11%	6.53%	5.43%	5.79%	5.19%	6.31%	-	3.35%
Return on Equity (ROE)	17.43%	19.93%	14.41%	18.04%	19.85%	17.88%	19.60%	18.36%	22.95%	-	13.07%
Cash Return on Invested Capital (CROIC)	-23.65%	10.79%	11.98%	11.85%	10.71%	10.63%	10.63%	7.27%	5.45%	-	3.85%
Operating Return on Assets (OROA)	12.66%	13.09%	10.01%	12.42%	13.68%	14.06%	14.14%	13.62%	17.04%	-	10.38%
Return on Assets (ROA)	7.92%	8.47%	6.04%	8.11%	9.34%	8.70%	9.98%	9.52%	12.16%	-	7.29%
Return on Common Equity (ROCE)	17.43%	19.93%	14.41%	18.04%	19.85%	17.88%	19.60%	18.36%	22.95%	-	13.07%
Return on Equity Simple (ROE_SIMPLE)	8.58%	0.00%	13.32%	14.24%	15.05%	0.00%	16.05%	0.00%	0.00%	-	0.00%
Net Operating Profit after Tax (NOPAT)	49	59	41	55	62	60	62	63	81	15	46
NOPAT Margin	10.13%	11.84%	8.71%	10.95%	12.22%	11.22%	12.24%	11.65%	14.87%	-	8.61%
Net Nonoperating Expense Percent (NNEP)	1.89%	1.16%	1.15%	1.18%	1.01%	0.93%	0.83%	0.79%	0.82%	-	0.39%
Return On Investment Capital (ROIC_SIMPLE)	-	3.19%	-	-	-	3.19%	3.27%	3.22%	3.97%	0.73%	2.26%
Cost of Revenue to Revenue	62.47%	60.71%	61.29%	60.35%	59.54%	58.46%	59.09%	59.42%	55.60%	-	64.04%
SG&A Expenses to Revenue	24.38%	23.67%	27.10%	25.24%	24.72%	25.28%	25.14%	25.33%	24.95%	-	24.84%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-	0.00%
Operating Expenses to Revenue	24.38%	23.67%	27.10%	25.24%	24.72%	25.28%	25.14%	25.33%	24.95%	-	24.84%
Earnings before Interest and Taxes (EBIT)	65	78	54	73	81	88	81	84	107	31	62
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	79	92	68	87	96	102	95	98	121	45	76
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	2.11	2.25	2.58	2.36	2.81	3.06	2.76	2.71	3.20	-	2.15
Price to Tangible Book Value (P/TBV)	6.31	6.21	6.97	6.06	6.85	6.91	5.94	5.52	6.11	-	3.81
Price to Revenue (P/Rev)	1.23	1.36	1.57	1.45	1.76	1.97	1.80	1.82	2.23	-	1.47
Price to Earnings (P/E)	24.71	20.21	19.47	16.74	18.66	21.28	17.43	16.79	19.32	-	16.45
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-	0.00%
Earnings Yield	4.05%	4.95%	5.14%	5.97%	5.36%	4.70%	5.74%	5.96%	5.18%	-	6.08%
Enterprise Value to Invested Capital (EV/IC)	1.70	1.81	2.04	1.91	2.23	2.46	2.28	2.26	2.64	-	1.86
Enterprise Value to Revenue (EV/Rev)	1.58	1.69	1.89	1.75	2.06	2.23	2.05	2.06	2.47	-	1.70
Enterprise Value to EBITDA (EV/EBITDA)	13.48	12.00	11.88	10.53	11.85	12.71	11.04	10.99	12.59	-	10.75
Enterprise Value to EBIT (EV/EBIT)	17.73	15.04	14.48	12.71	14.21	15.15	12.98	12.84	14.53	-	12.86
Enterprise Value to NOPAT (EV/NOPAT)	23.17	19.77	19.15	16.80	18.78	20.64	17.57	17.41	19.70	-	17.82
Enterprise Value to Operating Cash Flow (EV/OCF)	18.92	15.60	15.58	14.82	18.50	19.40	18.21	24.48	36.55	-	34.49
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	16.65	16.88	16.11	20.95	23.30	21.72	32.01	50.61	-	49.91
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.62	0.57	0.56	0.53	0.51	0.45	0.42	0.40	0.37	-	0.37
Long-Term Debt to Equity	0.50	0.48	0.48	0.46	0.44	0.42	0.40	0.38	0.35	-	0.34
Financial Leverage	0.44	0.64	0.63	0.57	0.53	0.47	0.45	0.42	0.40	-	0.36
Leverage Ratio	1.89	2.10	2.02	1.99	1.96	1.92	1.85	1.83	1.81	-	1.73
Compound Leverage Factor	1.53	1.79	1.62	1.71	1.72	1.72	1.68	1.67	1.69	-	1.57
Debt to Total Capital	38.32%	36.34%	35.77%	34.61%	33.78%	31.21%	29.62%	28.55%	27.23%	-	27.21%
Short-Term Debt to Total Capital	7.23%	5.91%	5.12%	4.63%	4.32%	2.24%	1.15%	1.60%	1.69%	-	2.61%
Long-Term Debt to Total Capital	31.09%	30.43%	30.65%	29.98%	29.46%	28.97%	28.47%	26.95%	25.54%	-	24.60%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-	0.00%
Common Equity to Total Capital	61.68%	63.66%	64.23%	65.39%	66.22%	68.79%	70.38%	71.45%	72.77%	-	72.79%
Debt to EBITDA	3.09	2.46	2.13	1.95	1.84	1.66	1.48	1.43	1.33	-	1.61
Net Debt to EBITDA	2.95	2.32	2.02	1.81	1.71	1.50	1.32	1.29	1.20	-	1.48
Long-Term Debt to EBITDA	2.51	2.06	1.82	1.69	1.60	1.54	1.42	1.35	1.25	-	1.46
Debt to NOPAT	5.32	4.05	3.43	3.12	2.91	2.70	2.36	2.27	2.09	-	2.67
Net Debt to NOPAT	5.07	3.82	3.25	2.89	2.71	2.44	2.10	2.04	1.88	-	2.46
Long-Term Debt to NOPAT	4.31	3.39	2.94	2.70	2.54	2.51	2.27	2.14	1.96	-	2.41
Altman Z-Score	3.21	3.37	3.75	3.58	3.84	4.13	4.11	4.25	4.85	-	4.20
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	2.24	2.25	2.50	2.40	2.34	2.43	2.62	2.74	2.94	-	3.29
Quick Ratio	0.97	1.03	1.12	1.12	1.10	1.12	1.17	1.13	1.11	-	1.22
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-448	89	66	64	39	35	17	-49	-82	-126	-87
Operating Cash Flow to CapEx	581.61%	540.68%	483.31%	530.78%	517.74%	873.59%	466.43%	101.16%	117.55%	-	517.92%
Free Cash Flow to Firm to Interest Expense	-36.72	7.89	6.27	6.26	4.01	3.83	2.26	-6.89	-11.33	-	-14.92
Operating Cash Flow to Interest Expense	4.60	5.27	4.90	6.21	4.54	7.80	6.96	1.19	1.69	-	7.54
Operating Cash Flow Less CapEx to Interest Expense	3.81	4.29	3.89	5.04	3.66	6.91	5.47	0.01	0.25	-	6.08
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.95	0.83	0.86	0.86	0.85	0.85	0.88	0.88	0.86	-	0.88
Accounts Receivable Turnover	4.22	4.04	4.22	3.99	3.73	3.65	3.93	3.94	3.90	-	4.07
Inventory Turnover	1.98	1.79	1.85	1.89	1.85	1.79	1.79	1.74	1.58	-	1.55
Fixed Asset Turnover	13.84	12.51	12.30	12.13	12.18	12.38	12.43	12.55	12.72	-	12.89
Accounts Payable Turnover	7.20	6.98	8.73	7.55	6.54	5.89	6.90	6.39	5.87	-	7.17
Days Sales Outstanding (DSO)	86.47	90.24	86.51	91.41	97.79	99.97	92.79	92.58	93.70	-	89.76
Days Inventory Outstanding (DIO)	184.72	204.34	197.22	192.76	197.82	204.12	203.37	209.89	231.14	-	235.01
Days Payable Outstanding (DPO)	50.68	52.28	41.83	48.34	55.83	61.98	52.92	57.11	62.17	-	50.90
Cash Conversion Cycle (CCC)	220.52	242.30	241.90	235.83	239.78	242.12	243.24	245.36	262.67	-	273.87
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	1,797	1,798	1,794	1,790	1,819	1,823	1,840	1,902	1,982	1,964	1,972
Invested Capital Turnover	1.25	1.06	1.07	1.09	1.09	1.11	1.13	1.13	1.12	-	1.13
Increase / (Decrease) in Invested Capital	498	-31	-26	-8.77	22	25	46	112	163	141	132
Enterprise Value (EV)	3,054	3,256	3,655	3,425	4,057	4,483	4,194	4,296	5,241	-	3,661
Market Capitalization	2,386	2,626	3,035	2,837	3,472	3,954	3,692	3,793	4,742	-	3,156
Book Value per Share	$35.83	$37.10	$37.72	$38.74	$40.38	$42.38	$43.73	$45.88	$48.55	$48.33	$48.59
Tangible Book Value per Share	$12.01	$13.43	$13.98	$15.09	$16.59	$18.76	$20.32	$22.54	$25.43	$27.24	$27.42
Total Capital	1,829	1,835	1,829	1,837	1,864	1,880	1,900	1,959	2,037	2,014	2,015
Total Debt	701	667	654	636	630	587	563	559	555	536	548
Total Long-Term Debt	569	559	560	551	549	545	541	528	520	499	496
Net Debt	669	630	620	588	585	530	502	502	499	487	505
Capital Expenditures (CapEx)	9.67	11	11	12	8.56	8.18	11	8.45	10	8.15	8.45
Debt-free, Cash-free Net Working Capital (DFCFNWC)	763	758	756	757	790	791	811	881	979	1,017	1,037
Debt-free Net Working Capital (DFNWC)	794	795	791	804	835	848	872	938	1,035	1,066	1,080
Net Working Capital (NWC)	662	687	697	719	755	806	850	907	1,000	1,029	1,027
Net Nonoperating Expense (NNE)	8.94	8.25	7.98	7.65	6.33	5.39	4.66	4.31	4.45	3.12	1.98
Net Nonoperating Obligations (NNO)	669	630	620	588	585	530	502	502	499	487	505
Total Depreciation and Amortization (D&A)	14	14	14	14	15	14	14	14	14	14	14
Debt-free, Cash-free Net Working Capital to Revenue	39.37%	39.29%	39.16%	38.71%	40.11%	39.36%	39.60%	42.23%	46.05%	-	48.19%
Debt-free Net Working Capital to Revenue	41.02%	41.19%	40.94%	41.14%	42.41%	42.21%	42.56%	44.96%	48.66%	-	50.19%
Net Working Capital to Revenue	34.20%	35.58%	36.09%	36.79%	38.32%	40.11%	41.49%	43.46%	47.05%	-	47.75%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$1.29	$1.60	$1.05	$1.53	$1.81	$1.78	$1.88	$1.92	$2.50	$0.39	$1.44
Adjusted Weighted Average Basic Shares Outstanding	31.48M	31.46M	31.14M	30.96M	30.57M	30.80M	30.58M	30.52M	30.55M	30.54M	30.23M
Adjusted Diluted Earnings per Share	$1.28	$1.60	$1.05	$1.53	$1.80	$1.76	$1.87	$1.91	$2.48	$0.38	$1.43
Adjusted Weighted Average Diluted Shares Outstanding	31.56M	31.53M	31.25M	31.07M	30.74M	30.96M	30.81M	30.68M	30.78M	30.76M	30.42M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	31.49M	31.09M	31.01M	30.57M	30.52M	30.58M	30.51M	30.53M	30.56M	30.18M	29.88M
Normalized Net Operating Profit after Tax (NOPAT)	49	59	41	55	62	60	62	63	81	22	46
Normalized NOPAT Margin	10.13%	11.84%	8.71%	10.95%	12.22%	11.22%	12.24%	11.65%	14.87%	-	8.61%
Pre Tax Income Margin	10.77%	13.42%	9.34%	12.40%	14.12%	14.79%	14.59%	14.21%	18.38%	-	10.63%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	5.31	6.86	5.13	7.12	8.29	9.62	11.07	11.70	14.87	-	10.68
NOPAT to Interest Expense	4.05	5.17	3.85	5.40	6.31	6.54	8.45	8.77	11.22	-	7.84
EBIT Less CapEx to Interest Expense	4.51	5.88	4.12	5.95	7.41	8.73	9.57	10.52	13.42	-	9.23
NOPAT Less CapEx to Interest Expense	3.26	4.19	2.83	4.23	5.43	5.65	6.96	7.60	9.78	-	6.39
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-	0.00%
Augmented Payout Ratio	0.00%	12.15%	27.42%	39.12%	50.93%	42.53%	30.03%	19.62%	6.74%	-	41.96%

Financials Breakdown Chart

Key Financial Trends

Dorman Products has shown solid top‑line growth and stable profitability over the last four years, with quarterly results reflecting a larger, more mature business. Revenue has trended higher (roughly mid‑$400s to mid‑$500s millions per quarter from 2022 through 2025), gross margins have remained in the mid‑40% range, and earnings per share have advanced alongside rising net income. The company has also been actively returning capital through share repurchases, while gradually deleveraging the balance sheet. Cash flow from operations has remained positive across periods, though financing activities have been a net use of cash in several quarters due to debt repayments and buybacks.

Revenue has grown meaningfully from about $413.5M in Q3 2022 to about $543.7M in Q3 2025, indicating sustained demand and scale growth.
Gross margin has stayed in the mid‑40% range (roughly 42–44%), signaling a stable profitability baseline across 2023–2025.
Net income to common shareholders rose notably over this period, with Q3 2025 at about $75.4M versus roughly $30.6M in Q3 2022, reflecting improved profitability.
Earnings per share moved higher, with Q3 2025 basic EPS around $2.50 and diluted around $2.48, up from about $1.29 (basic) in Q3 2022.
Long‑term debt stepped down over time (e.g., ~473.4M in Q3 2022 down to ~421.1M by Q3 2025), signaling deleveraging and improved balance sheet flexibility.

Inventories and accounts receivable have trended higher, contributing to larger working‑capital needs and more pronounced changes in operating assets and liabilities across quarters.
Capital expenditures are moderate and largely maintenance‑oriented, with quarterly PPE purchases generally in the low to mid single‑digit tens of millions range (e.g., around $8–11M per quarter in recent periods).

Quarterly earnings can swing meaningfully; for example, Q4 2025 net income to common shareholders was about $12.2M, a sharp decline from Q3 2025’s ~$75.4M, suggesting seasonality or one‑offs impacting quarterly results.
Net cash from financing activities has been a user of cash in several 2025 quarters due to debt repayments and stock repurchases (e.g., Q4 2025 net cash from financing activities around −$39.7M).

05/14/26 05:45 AM ETAI Generated. May Contain Errors.

Dorman Products Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Dorman Products' financial year ends in December. Their financial year 2025 ended on December 31, 2025.

Dorman Products' net income appears to be on an upward trend, with a most recent value of $204.19 million in 2025, rising from $92.33 million in 2015. The previous period was $190.00 million in 2024. View Dorman Products' forecast to see where analysts expect Dorman Products to go next.

Dorman Products' total operating income in 2025 was $299.55 million, based on the following breakdown:

Total Gross Profit: $897.74 million
Total Operating Expenses: $598.19 million

Over the last 10 years, Dorman Products' total revenue changed from $802.96 million in 2015 to $2.13 billion in 2025, a change of 165.3%.

Dorman Products' total liabilities were at $1.02 billion at the end of 2025, a 10.2% decrease from 2024, and a 878.5% increase since 2015.

In the past 10 years, Dorman Products' cash and equivalents has ranged from $36.81 million in 2023 to $155.58 million in 2020, and is currently $49.44 million as of their latest financial filing in 2025.

Over the last 10 years, Dorman Products' book value per share changed from 14.59 in 2015 to 48.33 in 2025, a change of 231.2%.

Related Companies

Financial statements for NASDAQ:DORM last updated on 5/8/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Dorman Products (DORM) Financials

Financials Breakdown Chart

Key Financial Trends

Dorman Products Financials - Frequently Asked Questions

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Dorman Products (DORM) Financials

Annual Income Statements for Dorman Products

Quarterly Income Statements for Dorman Products

Annual Cash Flow Statements for Dorman Products

Quarterly Cash Flow Statements for Dorman Products

Annual Balance Sheets for Dorman Products

Quarterly Balance Sheets for Dorman Products

Annual Metrics And Ratios for Dorman Products

Quarterly Metrics And Ratios for Dorman Products

Financials Breakdown Chart

Key Financial Trends

Dorman Products Financials - Frequently Asked Questions

When does Dorman Products' fiscal year end?

How has Dorman Products' net income changed over the last 10 years?

What is Dorman Products' operating income?

How has Dorman Products' revenue changed over the last 10 years?

How much debt does Dorman Products have?

How much cash does Dorman Products have?

How has Dorman Products' book value per share changed over the last 10 years?

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools